CVS Health Corp (CVS)

NYSE
Currency in USD
67.05
-1.59(-2.32%)
Closed
After Hours
67.20+0.14(+0.21%)
CVS Scorecard
Full Analysis
Management has been aggressively buying back shares
Fair Value
Day's Range
67.0168.69
52 wk Range
43.5680.75
CVS Health Corp is currently considered to be UndervaluedExplore our list of undervalued stocks for hidden opportunities
Key Statistics
Edit
Prev. Close
68.64
Open
68.46
Day's Range
67.01-68.69
52 wk Range
43.56-80.75
Volume
18.11M
Average Volume (3m)
11.26M
1-Year Change
-14.56%
Book Value / Share
60.04
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CVS Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
72.26
Upside
+7.77%
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 3 consecutive years
Show more

CVS Health Corp Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, medical spend management services, and other administrative services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.

CVS Health Corp SWOT Analysis


Healthcare Titan
CVS Health, a $367 billion revenue giant, navigates challenges in Medicare Advantage and retail pharmacy while leveraging its unique integrated healthcare model
Strategic Shift
Explore CVS's efforts to improve Medicare Advantage margins through benefit adjustments and plan design changes, potentially boosting profitability
Market Valuation
With an average analyst price target of $69.70, CVS trades at attractive multiples compared to peers, suggesting potential upside for investors
Future Prospects
Learn how CVS's integrated model, leadership changes, and potential restructuring could drive growth and unlock shareholder value in the evolving healthcare landscape
Read full SWOT analysis

CVS Health Corp Earnings Call Summary for Q3/2024

  • Q3 2024: CVS Health reports $95.4B revenue (+6% YoY), adjusted EPS of $1.09; plans to close 270 stores by 2025
  • Healthcare benefits segment posts $924M adjusted operating loss; $1.1B premium deficiency reserve impacts results
  • Leadership changes: Prem Shah as Group President, Steve Nelson as Aetna President; multi-year cost savings initiative targets $500M+ in 2025
  • No formal 2024 outlook; aims for 3-5% target margins by 2025; expects earnings decline in pharmacy segment, improvement in healthcare benefits
  • Pharmacy script share up to 27.3%; CostVantage program has over 50% client participation; Signify volume increased 37% YoY
Last Updated: 11/07/2024, 03:42 AM
Read Full Transcript

Compare CVS to Peers and Sector

Metrics to compare
CVS
Peers
Sector
Relationship
P/E Ratio
18.3x14.8x−0.5x
PEG Ratio
−0.42−0.360.00
Price/Book
1.1x4.2x2.6x
Price / LTM Sales
0.2x1.5x3.0x
Upside (Analyst Target)
8.9%21.5%55.2%
Fair Value Upside
Unlock21.7%9.7%Unlock

Analyst Ratings

19 Buy
9 Hold
0 Sell
Ratings:
28 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 72.26
(+7.77% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 3.66%
Dividend Yield
3.97%
Industry Median 1.37%
Annualized payout
2.66
Paid quarterly
5-Years Growth
+5.87%
Growth Streak

Earnings

Latest Release
Feb 12, 2025
EPS / Forecast
1.19 / 1.00
Revenue / Forecast
97.70B / 96.97B
EPS Revisions
Last 90 days

People Also Watch

68.67
KO
-1.49%
24.26
INTC
+1.25%
335.66
V
-1.13%
163.63
JNJ
+0.37%
93.11
MRK
-1.71%

FAQ

What Is the CVS Health Corp (CVS) Stock Price Today?

The CVS Health Corp stock price today is 67.05

What Stock Exchange Does CVS Health Corp Trade On?

CVS Health Corp is listed and trades on the NYSE stock exchange.

What Is the Stock Symbol for CVS Health Corp?

The stock symbol for CVS Health Corp is "CVS."

Does CVS Health Corp Pay Dividends? What’s The Current Dividend Yield?

The CVS Health Corp dividend yield is 3.97%.

What Is the CVS Health Corp Market Cap?

As of today, CVS Health Corp market cap is 84.54B.

What is CVS Health Corp Earnings Per Share?

The CVS Health Corp EPS is 3.66.

What Is the Next CVS Health Corp Earnings Date?

CVS Health Corp will release its next earnings report on Apr 30, 2025.

From a Technical Analysis Perspective, Is CVS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.